Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 4,520 shares at $23.79 ($108K) on 2024-08-20, disclosed to the SEC on 2024-08-22.
Seasonal sale ($108k) by President and CEO — this insider has traded DNLI in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.79 | 2,260 | $54K | 50.0% |
| 2 | $23.79 | 2,260 | $54K | 50.0% |
| Total | $23.79 avg | 4,520 | $108K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-02-15 | $332K | — | Filing → |